Pacifica Partners’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $10.4K | Buy |
+1,200
| New | +$10.4K | ﹤0.01% | 333 |
|
2024
Q2 | – | Sell |
-1,000
| Closed | -$4.99K | – | 533 |
|
2024
Q1 | $4.99K | Hold |
1,000
| – | – | ﹤0.01% | 409 |
|
2023
Q4 | $8.81K | Hold |
1,000
| – | – | ﹤0.01% | 381 |
|
2023
Q3 | $7.27K | Hold |
1,000
| – | – | ﹤0.01% | 383 |
|
2023
Q2 | $9.94K | Hold |
1,000
| – | – | 0.01% | 298 |
|
2023
Q1 | $9.82K | Hold |
1,000
| – | – | 0.01% | 312 |
|
2022
Q4 | $4.11K | Hold |
1,000
| – | – | ﹤0.01% | 369 |
|
2022
Q3 | $7K | Hold |
1,000
| – | – | 0.01% | 325 |
|
2022
Q2 | $10K | Buy |
+1,000
| New | +$10K | 0.01% | 297 |
|
2021
Q4 | – | Sell |
-300
| Closed | -$7K | – | 479 |
|
2021
Q3 | $7K | Sell |
300
-3,650
| -92% | -$85.2K | 0.01% | 325 |
|
2021
Q2 | $50K | Buy |
3,950
+300
| +8% | +$3.8K | 0.04% | 151 |
|
2021
Q1 | $47K | Buy |
3,650
+1,000
| +38% | +$12.9K | 0.04% | 147 |
|
2020
Q4 | $35K | Hold |
2,650
| – | – | 0.03% | 149 |
|
2020
Q3 | $39K | Hold |
2,650
| – | – | 0.04% | 133 |
|
2020
Q2 | $40K | Hold |
2,650
| – | – | 0.04% | 131 |
|
2020
Q1 | $38K | Buy |
2,650
+625
| +31% | +$8.96K | 0.05% | 135 |
|
2019
Q4 | $41K | Buy |
+2,025
| New | +$41K | 0.04% | 148 |
|